Largest health care companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
UnitedHealth Group leads the 170 health care companies ranked by cash on hand, at CHF 20.5B, ahead of Johnson & Johnson (CHF 16.6B) and Centene (CHF 15.1B). Figures as of 19 Nov 2026, 12:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupCHF 20.5B
- Median
- CHF 489.3M
- Combined market value
- CHF 7.67T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | UnitedHealth GroupUNH · Health Care | CHF 20.5B | CHF 264.2B | CHF 294.91 | 10.21% down | 12% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | CHF 16.6B | CHF 553.3B | CHF 229.84 | 2.15% down | 34% up | ||
| 3 | CenteneCNC · Health Care | CHF 15.1B | CHF 28.1B | CHF 56.85 | 7.03% down | 94% up | ||
| 4 | Merck & CoMRK · Health Care | CHF 12.3B | CHF 286.3B | CHF 116.12 | 3.90% down | 45% up | ||
| 5 | NovartisNVS · Health Care | CHF 9.6B | CHF 247.1B | CHF 130.81 | 2.46% down | 25% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | CHF 8.6B | CHF 102.6B | CHF 50.20 | 2.92% down | 30% up | ||
| 7 | Thermo Fisher ScientificTMO · Health Care | CHF 8.3B | CHF 216.3B | CHF 583.86 | 0.87% up | 21% up | ||
| 8 | Elevance HealthELV · Health Care | CHF 8B | CHF 73B | CHF 337.84 | 7.63% down | 28% up | ||
| 9 | AmgenAMGN · Health Care | CHF 7.7B | CHF 202.4B | CHF 374.12 | 3.07% down | 32% up | ||
| 10 | Abbott LaboratoriesABT · Health Care | CHF 7.2B | CHF 152.5B | CHF 88.06 | 0.22% down | 16% down | ||
| 11 | BioNTechBNTX · Health Care | CHF 7.2B | CHF 17.4B | CHF 70.17 | 1.89% down | 14% down | ||
| 12 | SanofiSNY · Health Care | CHF 7.2B | CHF 95.4B | CHF 39.71 | 0.86% down | 4% down | ||
| 13 | CVS HealthCVS · Health Care | CHF 7.1B | CHF 87.7B | CHF 68.56 | 5.20% down | 7% up | ||
| 14 | Cigna GroupCI · Health Care | CHF 6.5B | CHF 63.4B | CHF 240.52 | 2.96% down | 6% up | ||
| 15 | Gilead SciencesGILD · Health Care | CHF 6.4B | CHF 176.6B | CHF 142.42 | 0.75% down | 35% up | ||
| 16 | Eli LillyLLY · Health Care | CHF 6.1B | CHF 1.04T | CHF 1,165.41 | 2.32% down | 33% up | ||
| 17 | AstraZenecaAZN · Health Care | CHF 4.8B | CHF 233.7B | CHF 150.66 | 1.93% down | 1% up | ||
| 18 | AbbVieABBV · Health Care | CHF 4.4B | CHF 426.1B | CHF 241.05 | 2.33% down | 25% up | ||
| 19 | Vertex PharmaceuticalsVRTX · Health Care | CHF 4.3B | CHF 114.6B | CHF 452.13 | 0.42% up | 27% up | ||
| 20 | Cardinal HealthCAH · Health Care | CHF 4.1B | CHF 54.2B | CHF 234.57 | 0.33% down | 34% up | ||
| 21 | DanaherDHR · Health Care | CHF 3.9B | CHF 135.5B | CHF 192.65 | 1.24% up | 3% up | ||
| 22 | BeOne MedicinesONC · Health Care | CHF 3.8B | CHF 38.9B | CHF 340.16 | 2.34% down | 16% up | ||
| 23 | GSKGSK · Health Care | CHF 3.8B | CHF 82.1B | CHF 40.94 | 1.34% down | 5% up | ||
| 24 | GE HealthCare TechnologiesGEHC · Health Care | CHF 3.8B | CHF 31.9B | CHF 70.51 | 2.22% up | 12% up | ||
| 25 | CencoraCOR · Health Care | CHF 3.7B | CHF 56B | CHF 293.56 | 0.64% down | 4% down | ||
| 26 | Molina HealthcareMOH · Health Care | CHF 3.6B | CHF 9.1B | CHF 174.09 | 6.62% down | 54% up | ||
| 27 | HumanaHUM · Health Care | CHF 3.5B | CHF 39.1B | CHF 325.14 | 12.98% down | 73% up | ||
| 28 | StrykerSYK · Health Care | CHF 3.4B | CHF 102.1B | CHF 268.14 | 0.19% up | 12% down | ||
| 29 | McKessonMCK · Health Care | CHF 3.4B | CHF 105.5B | CHF 913.98 | 0.66% down | 28% up | ||
| 30 | Novo NordiskNVO · Health Care | CHF 3.3B | CHF 146.5B | CHF 33.23 | 3.12% down | 17% down | ||
| 31 | Takeda PharmaceuticalTAK · Health Care | CHF 3.1B | CHF 57.3B | CHF 17.93 | 1.71% down | 51% up | ||
| 32 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 3B | CHF 41.5B | CHF 35.59 | 0.92% down | 74% up | ||
| 33 | argenxARGX · Health Care | CHF 2.9B | CHF 49.9B | CHF 793.30 | 0.66% down | 2% up | ||
| 34 | Intuitive SurgicalISRG · Health Care | CHF 2.8B | CHF 123B | CHF 354.79 | 2.23% down | 24% down | ||
| 35 | Regeneron PharmaceuticalsREGN · Health Care | CHF 2.6B | CHF 82.4B | CHF 796.91 | 1.28% down | 28% up | ||
| 36 | Koninklijke PhilipsPHG · Health Care | CHF 2.6B | CHF 24.6B | CHF 25.12 | 0.27% down | 12% up | ||
| 37 | IncyteINCY · Health Care | CHF 2.6B | CHF 20.2B | CHF 99.28 | 1.08% down | 16% up | ||
| 38 | BiogenBIIB · Health Care | CHF 2.5B | CHF 31.3B | CHF 211.89 | 0.25% up | 49% up | ||
| 39 | Edwards LifesciencesEW · Health Care | CHF 2.5B | CHF 51B | CHF 88.69 | 0.19% down | 25% up | ||
| 40 | Tenet HealthcareTHC · Health Care | CHF 2.4B | CHF 18.2B | CHF 228.69 | 3.80% down | 45% up | ||
| 41 | Oscar HealthOSCR · Health Care | CHF 2.3B | CHF 7.2B | CHF 23.24 | 7.61% down | 112% up | ||
| 42 | ModernaMRNA · Health Care | CHF 2.2B | CHF 67.1B | CHF 165.86 | 4.84% down | 780% up | ||
| 43 | ZoetisZTS · Health Care | CHF 1.9B | CHF 29.3B | CHF 72.12 | 2.50% up | 26% down | ||
| 44 | IQVIA HoldingsIQV · Health Care | CHF 1.7B | CHF 35.8B | CHF 217.31 | 0.09% up | 19% up | ||
| 45 | Baxter InternationalBAX · Health Care | CHF 1.7B | CHF 11.4B | CHF 22.05 | 1.55% up | 50% up | ||
| 46 | Boston ScientificBSX · Health Care | CHF 1.7B | CHF 53.3B | CHF 36.78 | 1.42% up | 55% down | ||
| 47 | MedtronicMDT · Health Care | CHF 1.6B | CHF 108.6B | CHF 84.89 | 1.56% down | 1% up | ||
| 48 | MedlineMDLN · Health Care | CHF 1.6B | CHF 43.4B | CHF 33.00 | 3.93% up | 4% down | ||
| 49 | Agilent TechnologiesA · Health Care | CHF 1.5B | CHF 42.1B | CHF 149.46 | 2.97% up | 22% up | ||
| 50 | Fresenius Medical CareFMS · Health Care | CHF 1.5B | CHF 9.2B | CHF 17.66 | 3.41% down | 7% down | ||
| 51 | GenmabGMAB · Health Care | CHF 1.4B | CHF 26.5B | CHF 42.96 | 1.91% down | 70% up | ||
| 52 | Alnylam PharmaceuticalsALNY · Health Care | CHF 1.4B | CHF 16.9B | CHF 125.92 | 4.54% down | 66% down | ||
| 53 | United TherapeuticsUTHR · Health Care | CHF 1.3B | CHF 20.7B | CHF 486.59 | 1.16% down | 22% up | ||
| 54 | AlconALC · Health Care | CHF 1.3B | CHF 30.5B | CHF 63.43 | 1.55% up | 0% up | ||
| 55 | ResMedRMD · Health Care | CHF 1.2B | CHF 28.8B | CHF 204.48 | 2.00% up | 1% down | ||
| 56 | Roivant SciencesROIV · Health Care | CHF 1.2B | CHF 23.7B | CHF 32.64 | 0.05% up | 91% up | ||
| 57 | IlluminaILMN · Health Care | CHF 1.2B | CHF 26.8B | CHF 177.00 | 3.65% up | 76% up | ||
| 58 | Jazz PharmaceuticalsJAZZ · Health Care | CHF 1.2B | CHF 13.4B | CHF 208.83 | 2.93% up | 41% up | ||
| 59 | ViatrisVTRS · Health Care | CHF 1.1B | CHF 19.6B | CHF 17.09 | 0.83% down | 99% up | ||
| 60 | BioMarin PharmaceuticalBMRN · Health Care | CHF 1.1B | CHF 10B | CHF 51.77 | 4.99% up | 17% up | ||
| 61 | PfizerPFE · Health Care | CHF 962.5M | CHF 134.8B | CHF 23.65 | 1.44% down | 15% up | ||
| 62 | Align TechnologyALGN · Health Care | CHF 922.8M | CHF 9.7B | CHF 138.19 | 0.31% up | 23% up | ||
| 63 | NateraNTRA · Health Care | CHF 907M | CHF 35.4B | CHF 244.00 | 0.71% up | 28% up | ||
| 64 | HCA HealthcareHCA · Health Care | CHF 876.5M | CHF 83.9B | CHF 401.48 | 4.96% down | 0% up | ||
| 65 | PTC TherapeuticsPTCT · Health Care | CHF 829.9M | CHF 4.2B | CHF 50.76 | 0.22% down | 21% down | ||
| 66 | RevvityRVTY · Health Care | CHF 775.3M | CHF 14.3B | CHF 128.47 | 3.14% up | 62% up | ||
| 67 | DexComDXCM · Health Care | CHF 773.5M | CHF 25.9B | CHF 69.55 | 0.59% up | 41% up | ||
| 68 | GrifolsGRFS · Health Care | CHF 771.5M | CHF 4.9B | CHF 7.14 | 1.85% down | 0% up | ||
| 69 | ImmunovantIMVT · Health Care | CHF 760.3M | CHF 5.8B | CHF 27.96 | 0.12% down | 46% up | ||
| 70 | Legend BiotechLEGN · Health Care | CHF 760.1M | CHF 2.7B | CHF 13.70 | 0.87% up | 41% down | ||
| 71 | SolventumSOLV · Health Care | CHF 740M | CHF 12.4B | CHF 72.89 | 0.49% up | 9% up | ||
| 72 | QiagenQGEN · Health Care | CHF 707.1M | CHF 8.6B | CHF 41.77 | 0.38% down | 9% up | ||
| 73 | Caris Life SciencesCAI · Health Care | CHF 671.1M | CHF 4.7B | CHF 16.43 | 2.21% down | 19% down | ||
| 74 | West Pharmaceutical ServicesWST · Health Care | CHF 666.9M | CHF 23.7B | CHF 340.52 | 2.44% down | 57% up | ||
| 75 | RadNetRDNT · Health Care | CHF 646.6M | CHF 4.8B | CHF 60.53 | 4.14% down | 9% down | ||
| 76 | InsuletPODD · Health Care | CHF 603.5M | CHF 8.2B | CHF 117.98 | 3.69% down | 55% down | ||
| 77 | Neurocrine BiosciencesNBIX · Health Care | CHF 600.9M | CHF 13.9B | CHF 137.26 | 1.84% down | 17% up | ||
| 78 | Ascendis PharmaASND · Health Care | CHF 576.1M | CHF 14.9B | CHF 227.84 | 0.32% down | 29% up | ||
| 79 | DaVitaDVA · Health Care | CHF 570.1M | CHF 8.6B | CHF 136.36 | 6.48% down | 40% up | ||
| 80 | ICONICLR · Health Care | CHF 545.6M | CHF 12.3B | CHF 164.48 | 0.07% up | 23% up | ||
| 81 | Becton, DickinsonBDX · Health Care | CHF 540.2M | CHF 49.6B | CHF 182.12 | 0.31% up | 45% up | ||
| 82 | LivaNovaLIVN · Health Care | CHF 535.7M | CHF 4.4B | CHF 79.68 | 2.85% up | 77% up | ||
| 83 | Royalty PharmaRPRX · Health Care | CHF 521.4M | CHF 33.3B | CHF 57.88 | 0.01% down | 79% up | ||
| 84 | Zimmer Biomet HoldingsZBH · Health Care | CHF 498.9M | CHF 16.5B | CHF 87.08 | 1.20% up | 16% up | ||
| 85 | WatersWAT · Health Care | CHF 495.4M | CHF 77.2B | CHF 392.84 | 3.63% up | 23% up | ||
| 86 | ABIVAXABVX · Health Care | CHF 483.2M | CHF 6.2B | CHF 70.65 | 2.11% up | 32% down | ||
| 87 | BridgeBio PharmaBBIO · Health Care | CHF 480.5M | CHF 12.8B | CHF 65.75 | 1.58% up | 21% up | ||
| 88 | RepligenRGEN · Health Care | CHF 477.1M | CHF 9.3B | CHF 145.53 | 6.47% up | 12% up | ||
| 89 | Smith & NephewSNN · Health Care | CHF 469.5M | CHF 10.7B | CHF 25.55 | 0.62% down | 5% down | ||
| 90 | Elanco Animal HealthELAN · Health Care | CHF 459.3M | CHF 11.2B | CHF 22.50 | 3.29% up | 26% up | ||
| 91 | Labcorp HoldingsLH · Health Care | CHF 448.6M | CHF 25.4B | CHF 312.50 | 0.69% up | 42% up | ||
| 92 | Bio-Rad LaboratoriesBIO · Health Care | CHF 446.5M | CHF 8.4B | CHF 311.99 | 3.34% up | 22% up | ||
| 93 | Globus MedicalGMED · Health Care | CHF 443.5M | CHF 7.9B | CHF 59.44 | 0.77% up | 14% down | ||
| 94 | InsmedINSM · Health Care | CHF 430.2M | CHF 22.2B | CHF 100.97 | 1.69% down | 40% down | ||
| 95 | Ensign GroupENSG · Health Care | CHF 424.7M | CHF 9B | CHF 154.22 | 1.63% down | 2% up | ||
| 96 | Medpace HoldingsMEDP · Health Care | CHF 418.9M | CHF 15.3B | CHF 545.19 | 0.95% down | 10% up | ||
| 97 | Krystal BiotechKRYS · Health Care | CHF 418.3M | CHF 7.9B | CHF 265.77 | 5.62% up | 54% up | ||
| 98 | BillionToOneBLLN · Health Care | CHF 418M | CHF 3.7B | CHF 77.15 | 6.11% down | 4% down | ||
| 99 | ExelixisEXEL · Health Care | CHF 406.7M | CHF 14B | CHF 57.56 | 0.31% down | 63% up | ||
| 100 | 10x GenomicsTXG · Health Care | CHF 399.5M | CHF 6.3B | CHF 48.10 | 1.37% up | 247% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8428 CHF).
Questions and answers
Which health care companies rank first by cash on hand?
UnitedHealth Group (CHF 20.5B), Johnson & Johnson (CHF 16.6B) and Centene (CHF 15.1B) are the top three of the 170 health care companies ranked by cash on hand as of 19 Nov 2026, 12:23 UTC.
How many health care companies are in this ranking?
170 are ranked by cash on hand.
What are these health care companies worth together?
The 170 health care companies ranked by cash on hand have a combined market value of CHF 7.67T as of 19 Nov 2026, 12:23 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.